Evidence map›Paper›PMID 41862826›Full record

ArticleBMC infectious diseases2026

Progress of HIV care cascade and transition dynamics along the continuum of care among persons living with HIV in Ifakara, Tanzania: a prospective study.

Aneth Vedastus Kalinjuma, Aaloke Mody, Tracy Renée Glass, Maja Weisser, Ezekiel Luoga, Honorati Masanja, Fiona Vanobberghen, Kennedy Otwombe

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aneth Vedastus KalinjumaDepartment of Biomedical Research and Clinical Trials, Ifakara Health Institute, 463 Kiko Avenue, Mikocheni, P.O. Box 78383, Dar es Salaam, Tanzania. avedastus@ihi.or.tz.ORCID http://orcid.org/0000-0001-5862-9264
Aaloke ModyDepartment of Medicine, Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Tracy Renée GlassDepartment of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Maja WeisserDepartment of Biomedical Research and Clinical Trials, Ifakara Health Institute, 463 Kiko Avenue, Mikocheni, P.O. Box 78383, Dar es Salaam, Tanzania.
Ezekiel LuogaDepartment of Biomedical Research and Clinical Trials, Ifakara Health Institute, 463 Kiko Avenue, Mikocheni, P.O. Box 78383, Dar es Salaam, Tanzania.
Honorati MasanjaDepartment of Biomedical Research and Clinical Trials, Ifakara Health Institute, 463 Kiko Avenue, Mikocheni, P.O. Box 78383, Dar es Salaam, Tanzania.
Fiona Vanobberghen *Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Kennedy Otwombe *Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile cross-sectional assessments offer snapshots of care cascade progress, longitudinal analyses are essential to capture the dynamic engagement in care of people living with HIV (PLHIV). We assessed the advancement of the HIV cascade, engagement in care and factors associated with different transitions among PLHIV at the Chronic Disease Clinic of Ifakara, Ifakara, Tanzania, using both cross-sectional and longitudinal analyses.

methodsIn this prospective study, we included PLHIV enrolled in care from 04/2005 to 09/2022 and consented to participate in the Kilombero and Ulanga Antiretroviral Cohort. A cross-sectional care cascade was assessed descriptively. In longitudinal analysis, we used continuous-time, non-parametric multistate, and Cox proportional hazards models to assess engagement in care and factors associated with different transitions, respectively.

resultsOf the 11,591 PLHIV enrolled, 7,353 (63%) were female and 8,637 (75%) were adults aged 20–49 years. Cross-sectionally, 3,647 participants initiated on antiretroviral therapy (ART) were retained in care, and of these, 3,450 (95%) had a viral load < 1000 copies/mL as of September 2022. The repeated cross-sectional cascade showed the proportion of ART initiation increased over time (from 67% in the period 04/2005-01/2009 to 96% in 04/2019-09/2022). In longitudinal assessment, at 12 months, 45% were in care, and 24% were lost to follow-up (LTFU). After being LTFU, 34% returned to care within 12 months. Being on ART at baseline was associated with a reduced risk of LTFU (Hazard ratio [HR] = 0.71; 95% Confidence interval [CI]: 0.67–0.75) and an increased hazard of return to care after being LTFU (HR = 1.38; 95% CI: 1.31–1.45). PLHIV aged ≥ 15 years and being in WHO stage 3 (HR = 1.09; 95% CI: 1.03–1.16) and stage 4 (HR = 1.31; 95% CI: 1.21–1.42) were associated with an elevated risk of LTFU, while WHO stage 4 (HR = 0.76; 95% CI: 0.69–0.83) was associated with a reduced hazard of returning to care after being LTFU.

conclusionsCross-sectional analyses showed a high proportion of viral load suppression, achieving the UNAIDS target among PLHIV retained in care. However, longitudinal models revealed that many PLHIV transitioned in-and-out of care. The first 12 months after enrolment and LTFU are critical periods that should be targeted for maximizing retention. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Continuity of Patient CareHIV InfectionsAdultAnti-HIV AgentsCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesTanzaniaViral LoadYoung AdultAnti-HIV AgentsCross-sectional care cascadeEngagement in HIV care and treatmentLongitudinal continuum of careMultistate modelsUNAIDS 95-95-95

Identifiers

PMID41862826
PMCPMC13127090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.